Stock Taper
GH
GUARDANT HEALTH, INC.
NASDAQ
$161.50
▼ DOWN 4.17% (-7.02)

KEY STATISTICS

Market Cap$21.67 B
52w High$176.58
52w Low$53.40
Dividend Yield
Frequency
P/E-46.28
Volume1.82M
Shares Out.134.20M

COMPANY

LEADERSHIP

Helmy Eltoukhy
CHIEF EXECUTIVE
Helmy Eltoukhy

COMPENSATION 2026

Salary$1
Stock Awards$0
Incentive Plan Pay$0
All Other Comp.$11,590
Total$11,591

ABOUT

SECTOR
Healthcare
WENT PUBLIC
October 4, 2018
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
2,498

PRICE TARGET

Target High$210.00
Target Low$150.00
Target Median$197.50
Target Consensus$193.07

UPCOMING EARNINGS

DateOct 28, 2026
DayWednesday
Rev. Est.$350.14M
OCT
28
WED

PRICE

$161.50 ▼ DOWN 4.17% (−$7.02)
$162$165$1689:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM161.50

About Guardant Health, Inc.

https://guardanthealth.com ↗

Guardant Health is a precision oncology company providing blood-based tests, data analytics, and research platforms for cancer detection, treatment, and clinical trial connectivity globally.

INDUSTRY

Medical - Diagnostics & Research

A PRODUCT GUARDANT HEALTH, INC. IS KNOWN FOR

Shield™
Shield™

Shield™ is an FDA-approved blood-based colorectal cancer screening test utilizing AI for early detection, offering a less invasive alternative to colonoscopies and recognized as a TIME Best Invention of 2024.

Revenue by Products

IconPRODUCTQ3-2025Q4-2025Q1-2026Q2-2026
Oncology$184.4M $189.95M $204.95M $219.1M
Biopharma Data$54.73M $54.01M $52.98M $60.95M
Screening$24.11M $35.13M $41.59M $52.87M
Licensing Other$1.95M $2.18M $2.14M $2.06M

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
UNITED STATES$249.44M $263.55M $284.63M $318.04M
NonUS$15.76M $17.72M $17.04M $16.94M

RATINGS SNAPSHOT

Overall rating: C

DCFROEROAD/EP/EP/B
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2

TRADES BY CONGRESS

SENATE TRADES
Sheldon Whitehouse
Sheldon Whitehouse
Purchase
2025-11-21
HOUSE TRADES
Donald Sternoff Beyer
Donald Sternoff Beyer
Sale (Full)
2022-02-28
Donald Sternoff Beyer Jr.
Donald Sternoff Beyer Jr.
Sale (Full)
2022-02-28

INSIDER TRADES

DIRECTOR, OFFICER: CO-CHIEF EXECUTIVE OFFICER
Eltoukhy Helmy
Sale · 25.0K shares
2026-08-26
DIRECTOR, OFFICER: CO-CHIEF EXECUTIVE OFFICER
Eltoukhy Helmy
Sale · 30.0K shares
2026-08-26
DIRECTOR, OFFICER: CO-CHIEF EXECUTIVE OFFICER
Talasaz AmirAli
Sale · 9.0K shares
2026-08-21
DIRECTOR
MIGNONE ROBERTO
Purchase · 264 shares
2026-08-21

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 9
OVERWEIGHT 6
OUTPERFORM 6
21 GRADES IN THE LAST 12 MONTHS

SECTORS PEERS

PEERPRICE
VTRS$16.34COMPARE
SOLV$91.12COMPARE
ASND$247.91COMPARE
BBIO$76.60COMPARE
RVTY$128.80COMPARE
ICLR$170.02COMPARE
EHC$120.85COMPARE
IONS$61.05COMPARE